摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-2-(2-溴乙酰氨基)乙酰胺]-2,2,5,5-四甲基-1-吡咯烷基氧化物 | 100900-13-8

中文名称
3-2-(2-溴乙酰氨基)乙酰胺]-2,2,5,5-四甲基-1-吡咯烷基氧化物
中文别名
3-[2-(2-溴乙酰胺)乙酰胺]-2,2,5,5-四甲基-1-吡咯烷基氧化物;(S)-4-溴-ALPHA-甲基苄基醇
英文名称
3-(2-(2-Bromoacetamido)acetamido)-proxyl free radical
英文别名
——
3-2-(2-溴乙酰氨基)乙酰胺]-2,2,5,5-四甲基-1-吡咯烷基氧化物化学式
CAS
100900-13-8
化学式
C12H21BrN3O3
mdl
——
分子量
335.221
InChiKey
FCOQWAAKZGWIFF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    145-147 °C
  • 密度:
    1.4922 (rough estimate)
  • 稳定性/保质期:
    <p>遵照规定使用和储存,则不会分解。</p>

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    19
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    62.4
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 安全说明:
    S26,S36,S37,S39

SDS

SDS:9877678cbb402d59b5d0d56350da9bed
查看

反应信息

  • 作为反应物:
    描述:
    dimethyl(2,2'-bipyridine)platinum(II) 、 3-2-(2-溴乙酰氨基)乙酰胺]-2,2,5,5-四甲基-1-吡咯烷基氧化物丙酮 为溶剂, 以87%的产率得到[3-(2-(acetamido-C(2))acetamido)-2,2,5,5-tetramethylpyrrolidinyl-N-oxyl](2,2'-bipyridine)bromodimethylplatinum(IV)
    参考文献:
    名称:
    Stable Organoplatinum(IV) Complexes with Pendant Free Radicals
    摘要:
    Oxidative addition of 2-bromoacetamido derivatives of the stable, free-radical nitroxides tempo and proxyl (2,2,6,6-tetramethylpiperidinyl-N-oxyl and 2,2,5,5-tetramethylpyrrolidinyl-N-oxyl, respectively) to [PtMe(2)(bpy)] (bpy = 2,2(')-bipyridine) affords the novel organoplatinum-(IV) complexes [Pt{CH2C(O)NH-tempo}BrMe(2)(bpy)] (1), [Pt{CH2C(O)NH-proxyl}BrMe(2)(bpy)] (2), [Pt{CH2C(O)NHCH2-proxyl}BrMe(2)(bpy)] (3), [Pt{CH2C(O)NHCH2C(O)NH-proxyl}-BrMe(2)(bpy)] (4), and [Pt{CH2C(O)NH(CH2)(3) NHC(O)-proxyl}BrMe(2)(bpy)] (5) in good yields. The complexes exist as a mixture of trans (a) and cis (b) isomers and are the result of traits and cis oxidative addition, respectively. The broad H-1 NMR spectra and distinctive three-line pattern in the ESR spectra conclusively demonstrate the paramagnetic nature of the complexes. The X-ray structure of la was determined. Crystals of la are monoclinic, space group P2(1)/c, with a = 13.401(2) Angstrom, b = 16.979(1) Angstrom, c = 11.199(1) Angstrom, beta = 93.01(1)degrees, Z = 4, and R = 0.0499. The bromo and Pt-C sigma-bonded 4-(2-acetamido)-tempo ligands occupy a mutually trans arrangement about the octahedral platinum(IV) center. Complexes 1-5 are rare examples of stable organometallic species with pendant free radicals.
    DOI:
    10.1021/om00005a019
点击查看最新优质反应信息

文献信息

  • Stable Organoplatinum(IV) Complexes with Pendant Free Radicals
    作者:Louis M. Rendina、Jagadese J. Vittal、Richard J. Puddephatt
    DOI:10.1021/om00005a019
    日期:1995.5
    Oxidative addition of 2-bromoacetamido derivatives of the stable, free-radical nitroxides tempo and proxyl (2,2,6,6-tetramethylpiperidinyl-N-oxyl and 2,2,5,5-tetramethylpyrrolidinyl-N-oxyl, respectively) to [PtMe(2)(bpy)] (bpy = 2,2(')-bipyridine) affords the novel organoplatinum-(IV) complexes [PtCH2C(O)NH-tempo}BrMe(2)(bpy)] (1), [PtCH2C(O)NH-proxyl}BrMe(2)(bpy)] (2), [PtCH2C(O)NHCH2-proxyl}BrMe(2)(bpy)] (3), [PtCH2C(O)NHCH2C(O)NH-proxyl}-BrMe(2)(bpy)] (4), and [PtCH2C(O)NH(CH2)(3) NHC(O)-proxyl}BrMe(2)(bpy)] (5) in good yields. The complexes exist as a mixture of trans (a) and cis (b) isomers and are the result of traits and cis oxidative addition, respectively. The broad H-1 NMR spectra and distinctive three-line pattern in the ESR spectra conclusively demonstrate the paramagnetic nature of the complexes. The X-ray structure of la was determined. Crystals of la are monoclinic, space group P2(1)/c, with a = 13.401(2) Angstrom, b = 16.979(1) Angstrom, c = 11.199(1) Angstrom, beta = 93.01(1)degrees, Z = 4, and R = 0.0499. The bromo and Pt-C sigma-bonded 4-(2-acetamido)-tempo ligands occupy a mutually trans arrangement about the octahedral platinum(IV) center. Complexes 1-5 are rare examples of stable organometallic species with pendant free radicals.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物